{"trigger": ["The DNA and steroid binding domains of the <extra_id_0> glucocorticoid receptor <extra_id_2> Protein <extra_id_1> are not altered in mononuclear cells of treated CLL patients .", ""], "relation": []}
{"trigger": ["The aim of this study was to investigate whether mutations in the <extra_id_0> glucocorticoid receptor <extra_id_2> Protein <extra_id_1> could account for the increasing unresponsiveness of patients with chronic lymphatic leukemia ( CLL ) to combination chemotherapy .", ""], "relation": []}
{"trigger": ["The receptor was tested immunocytochemically , in steroid binding assays , and by a mutation screening ( denaturing gradient gel electrophoresis ) of the receptor - cDNA .", ""], "relation": []}
{"trigger": ["The receptor concentration , as measured by staining and steroid binding test , varied considerably but showed no clear correlation to clinical response .", ""], "relation": []}
{"trigger": ["Using a highly sensitive mutation screening assay of the DNA - and the steroid - binding region , none of the treated patients revealed any mutation , suggesting that the <extra_id_0> glucocorticoid receptor <extra_id_2> Protein <extra_id_1> in the CLL patients tested is not altered in these domains .", ""], "relation": []}
{"trigger": ["In one individual who had not been treated before analysis a silent mutation was found in one receptor allele .", ""], "relation": []}
{"trigger": ["The results suggest that mechanisms other than altered ligand or DNA binding of the receptor may be responsible for the lack of response to chemotherapy .", ""], "relation": []}
{"trigger": ["This conclusion is discussed in relation to the mechanism of corticoid resistance in mouse and human lymphoma cells in culture .", ""], "relation": []}
